Virax Biolabs Group Limited - SIC # 7690 -

Ticker Exchange SIC # Website Latest Ticker
VRAX Nasdaq 7690 viraxbiolabs.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Virax Biolabs Group Limited

Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection Syndromes - May 26th, 2026 5:30 am
Avalon Advanced Materials and Virax Biolabs Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - May 15th, 2026 7:00 am
Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders - Apr 14th, 2026 5:34 am
Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why - Jan 15th, 2026 10:00 am
Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement - Dec 4th, 2025 2:05 pm
Virax Biolabs Group Limited Announces $5 Million Private Placement - Dec 3rd, 2025 11:53 am
BC-Most Active Stocks - Dec 3rd, 2025 8:30 am
Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders - Dec 3rd, 2025 5:34 am
Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes - Nov 3rd, 2025 6:29 am
Virax Biolabs (VRAX) Falls 18% on Lack of Leads - Aug 27th, 2025 10:05 am
Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September - Aug 26th, 2025 5:30 am
EXCLUSIVE: Virax Biolabs Inks Research Pact To Advance Long COVID Diagnostic Studies - Aug 26th, 2025 5:15 am
Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy - Jul 29th, 2025 5:35 am
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency - Jul 18th, 2025 2:15 pm
Virax Biolabs Group Full Year 2025 Earnings: Misses Expectations - Jul 4th, 2025 5:07 am